Replies to post #32933 on Endonovo Therapeutics Inc (ENDV)

[John_Vallay]

Being on Fox, Newsweek and Bloomberg does not mean the business is good.
Many public companies advertise (pay money) to be interviewed on New To The Street

I am not bashing, I am just asking what will revenues be.

If Endonovo generated $100 million in revenues, that equates to 4 cents per share in revenue.

With 2.5 Billion in fully diluted shares the $100 million in revenue does not mean very much for the stock.

Then when you calculate the $20+ million in debt and that debt will be converted to common stock that 2.5 Billion will increase to a lot more, that will dilute shareholders so EVEN IF Endonovo can do $100 million in revenue, which I am not saying they won't or can't because I don't want to be labeled a basher, the billions of shares make it impossible for stock price appreciation.

Just stating numbers and avoiding opinions or being labeled a basher.